Trials / Withdrawn
WithdrawnNCT00202371
Transfusion Effects in Myelodysplastic Patients: Limiting Exposure
Transfusion Effects in Myelodysplastic Patients: Limiting Exposure (Temple)
- Status
- Withdrawn
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Sanquin Research & Blood Bank Divisions · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Accepted
Summary
The goal of this study was to compare a restrictive RBC transfusion policy (a Hb transfusion trigger: 7.2 gr/dl) with a more liberal RBC transfusion policy (a Hb transfusion trigger: 9.6 gr/dl) on physical fatigue.
Detailed description
The goal of this study was to compare a restrictive RBC transfusion policy (a Hb transfusion trigger of 7.2 gr/dl) with a more liberal RBC transfusion policy (a Hb transfusion trigger of 9.6 gr/dl) on physical fatigue.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Red Blood Cell transfusion |
Timeline
- Start date
- 2002-07-01
- Completion
- 2005-07-01
- First posted
- 2005-09-20
- Last updated
- 2023-11-24
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT00202371. Inclusion in this directory is not an endorsement.